Back to Search
August 8, 2023

What to Expect from the ARPKD EL-PFDD Meeting

On August 29, 2023 the PKD Foundation will hold its first ever Externally Led Patient-focused Drug Development (EL-PFDD) Meeting on Autosomal Recessive PKD (ARPKD) and Congenital Hepatic Fibrosis (CHF). Should you attend the meeting? What should you expect? Get answers to these questions and more by attending our webinar on August 8!

Learn more about this meeting here.


Franz Winklhofer, MD
James Valentine
Hyman, Phelps & McNamara 

James has worked the last 15 years as a champion for the patient voice as part of the regulatory process.  James previously worked at the FDA where he was a patient liaison, helping to incorporate the patient voice into medical product review across the FDA’s various medical product centers and review divisions.  There, he helped to develop and launch the Patient-Focused Drug Development initiative.

Franz Winklhofer, MD
Larry Bauer – Hyman, Phelps & McNamara

Larry worked at the NIH for 17 years in clinical research, followed by a position at the FDA as a Regulatory Scientist in the Center for Drug Evaluation and Research’s Rare Diseases Program, a group he co-founded and worked for 10 years, where he advanced rare disease drug development.

Related Resources

PRMRP funding for PKD research

PRMRP funding for PKD research

DOD's PRMRP PKD grant opportunities Join Dr. Cecilia Dupecher and the PKD Foundation on March 21 @ 12pm CST for a webinar on the DOD’s PRMRP PKD grant opportunities! This informational webinar will be aimed at PKD researchers and will review the relevant funding opportunities and tips on how to...